FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling Big FDA review coming this July. Here's what athletes and patients should know about BPC 157, TB 500, and the broader peptide conversation. Always speak with your physician before starting any new protocol. #bpc157 # FDA 483 vs. Warning Letter: Compliance Guide Quality Forward FDA issued a warning letter to a medical spa for failing to follow requirements that help ensure prescription drugs are safe and come from verified sources. These safeguards protect patients from potentially The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York